Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10910225rdf:typepubmed:Citationlld:pubmed
pubmed-article:10910225lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:10910225lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:10910225lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:10910225lifeskim:mentionsumls-concept:C0015133lld:lifeskim
pubmed-article:10910225lifeskim:mentionsumls-concept:C0356799lld:lifeskim
pubmed-article:10910225pubmed:issue7lld:pubmed
pubmed-article:10910225pubmed:dateCreated2000-12-28lld:pubmed
pubmed-article:10910225pubmed:abstractTextThe purpose of the present study was to evaluate the antitumor activity and toxicity of oral estramustine phosphate (EMP) in combination with oral etoposide in patients with hormone-refractory prostate cancer.lld:pubmed
pubmed-article:10910225pubmed:languageenglld:pubmed
pubmed-article:10910225pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10910225pubmed:citationSubsetIMlld:pubmed
pubmed-article:10910225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10910225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10910225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10910225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10910225pubmed:statusMEDLINElld:pubmed
pubmed-article:10910225pubmed:monthJullld:pubmed
pubmed-article:10910225pubmed:issn0919-8172lld:pubmed
pubmed-article:10910225pubmed:authorpubmed-author:KarashimaTTlld:pubmed
pubmed-article:10910225pubmed:authorpubmed-author:YamashitaYYlld:pubmed
pubmed-article:10910225pubmed:authorpubmed-author:SumiyoshiYYlld:pubmed
pubmed-article:10910225pubmed:authorpubmed-author:HashinoEElld:pubmed
pubmed-article:10910225pubmed:authorpubmed-author:NakatsuziHHlld:pubmed
pubmed-article:10910225pubmed:issnTypePrintlld:pubmed
pubmed-article:10910225pubmed:volume7lld:pubmed
pubmed-article:10910225pubmed:ownerNLMlld:pubmed
pubmed-article:10910225pubmed:authorsCompleteYlld:pubmed
pubmed-article:10910225pubmed:pagination243-7lld:pubmed
pubmed-article:10910225pubmed:dateRevised2006-10-30lld:pubmed
pubmed-article:10910225pubmed:meshHeadingpubmed-meshheading:10910225...lld:pubmed
pubmed-article:10910225pubmed:meshHeadingpubmed-meshheading:10910225...lld:pubmed
pubmed-article:10910225pubmed:meshHeadingpubmed-meshheading:10910225...lld:pubmed
pubmed-article:10910225pubmed:meshHeadingpubmed-meshheading:10910225...lld:pubmed
pubmed-article:10910225pubmed:meshHeadingpubmed-meshheading:10910225...lld:pubmed
pubmed-article:10910225pubmed:meshHeadingpubmed-meshheading:10910225...lld:pubmed
pubmed-article:10910225pubmed:meshHeadingpubmed-meshheading:10910225...lld:pubmed
pubmed-article:10910225pubmed:meshHeadingpubmed-meshheading:10910225...lld:pubmed
pubmed-article:10910225pubmed:meshHeadingpubmed-meshheading:10910225...lld:pubmed
pubmed-article:10910225pubmed:meshHeadingpubmed-meshheading:10910225...lld:pubmed
pubmed-article:10910225pubmed:meshHeadingpubmed-meshheading:10910225...lld:pubmed
pubmed-article:10910225pubmed:meshHeadingpubmed-meshheading:10910225...lld:pubmed
pubmed-article:10910225pubmed:meshHeadingpubmed-meshheading:10910225...lld:pubmed
pubmed-article:10910225pubmed:year2000lld:pubmed
pubmed-article:10910225pubmed:articleTitleOral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer.lld:pubmed
pubmed-article:10910225pubmed:affiliationDepartment of Urology, National Shikoku Cancer Center Hospital, Matsuyama, Ehime, Japan. ysumiyos@shikoku-cc.go.jplld:pubmed
pubmed-article:10910225pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10910225pubmed:publicationTypeClinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10910225lld:pubmed